Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid
US11173109B2 · kind B2 · utility
0Cited by
6References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2018 |
| Grant date | Nov 16, 2021 |
| Priority date | — |
| Expiry date | Dec 7, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition in the form of an injectable aqueous solution, wherein the pH is comprised from 6.0 to 8.0, includes at least:a) amylin, an amylin receptor agonist or an amylin analog; andb) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy, wherein the composition does not comprise a basal insulin wherein the isoelectric point pI is comprised from 5.8 to 8.5. The composition may further include a prandial insulin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.